We're making self-care as simple as it should be.
No ifs. No buts. No bullsh*t.
We dare to care with our brands, uniquely blending science and our consumer obsession for over 60 years.
We’re challenging the conventions of care and defining a whole new way to think about health – for our people, our communities, and our planet.
On February 19th, Sanofi announced that it has now finalized negotiations with CD&R and signed a share purchase agreement for the indirect transfer of a 50% stake in Opella. Bpifrance is expected to participate as a minority shareholder with a c.2% stake.
This announcement marks the next step in our journey of becoming a leading fast-moving consumer healthcare player globally. The support of CD&R will propel Opella´s growth and will broaden possibilities to expand our reach and to address the changing needs of consumer to make self-care as simple as it should be.
For more information, please find the press release for the announcement below.
-
According to Nicholas Hall's DB6 2024™.
- Opella data, Q4´2023 published financial results.
Have a question or simply want to know more?
Any question or adverse reaction related to our products must be addressed via www.sanofi.com.
